Pazopanib HCl | FDA Orange Book | Approved Drug Product List | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Pazopanib HCl
FDA Orange Book

Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

Contact Supplier

IOL Chemicals is an innovation-driven bulk drug, Intermediate and Specialty Chemicals company.

Contact Supplier

IKF/Pharmasynthese have been with fine chemicals market and APIs performance for more than 40 years.

Contact Supplier

medac CDMO: Tailored CDMO services for injectables in syringes, cartridges & vials – aseptic, reliable, flexible and a solution ahead.

Contact Supplier

Coral

Contact Supplier

ICE Pharma offers a unique range of bile acid products and best-in-class services for the pharmaceutical industry.

Contact Supplier

Pazopanib HCl

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

49 API Suppliers, 14 USDMF, 1 JDMF, 9 EU WC, 5 KDMF, 9 NDC API, 35 Listed Suppliers, $ API Reference Price

49 API Suppliers
14 USDMF
1 JDMF
9 EU WC
5 KDMF
9 NDC API
35 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

97 Drugs in Development

97 Drugs in Development

INTERMEDIATES

45 Intermediate Suppliers

45 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

75 FDF Dossiers, 8 FDA Orange Book, 28 Europe, 3 Canada, 12 Australia, 5 South Africa, 19 Listed Dossiers

75 FDF Dossiers
8 FDA Orange Book
28 Europe
3 Canada
12 Australia
5 South Africa
19 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 200MG BASE, TABLET;ORAL - EQ 400MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 200MG BASE
TABLET;ORAL - EQ 400MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 SPI Pharma, 5 DKSH, 1 Boai NKY Pharmaceuticals Ltd, 3 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 1 Kirsch Pharma, 1 ACG Worldwide, 2 Actylis, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 10 BASF, 1 Clariant, 10 Corel Pharma Chem, 3 DFE Pharma, 9 Gangwal Chemicals, 4 Ideal Cures, 1 Ingredion Pharma Solutions, 10 Kerry, 2 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 9 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nitika Pharmaceutical Specialities, 2 Novo Excipients, 3 Pharmatrans-Sanaq, 2 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 11 Roquette, 12 Seppic, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 9 Sigachi Industries, 3 Silverline Chemicals, 2 The Dow Chemical Company, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

41 Coating Systems & Additives, 30 Fillers, Diluents & Binders, 17 Solubilizers, 17 Controlled & Modified Release, 16 Thickeners and Stabilizers, 15 Disintegrants & Superdisintegrants, 13 Granulation, 13 Direct Compression, 10 Lubricants & Glidants, 10 Film Formers & Plasticizers, 9 Parenteral, 8 Co-Processed Excipients, 6 Rheology Modifiers, 5 Empty Capsules, 5 Coloring Agents, 5 Emulsifying Agents, 5 Topical, 4 Vegetarian Capsules, 4 Surfactant & Foaming Agents, 4 API Stability Enhancers, 4 Taste Masking, 4 Chewable & Orodispersible Aids

41 Coating Systems & Additives
30 Fillers, Diluents & Binders
17 Solubilizers
17 Controlled & Modified Release
16 Thickeners and Stabilizers
15 Disintegrants & Superdisintegrants
13 Granulation
13 Direct Compression
10 Lubricants & Glidants
10 Film Formers & Plasticizers
9 Parenteral
8 Co-Processed Excipients
6 Rheology Modifiers
5 Empty Capsules
5 Coloring Agents
5 Emulsifying Agents
5 Topical
4 Vegetarian Capsules
4 Surfactant & Foaming Agents
4 API Stability Enhancers
4 Taste Masking
4 Chewable & Orodispersible Aids

DIGITAL CONTENT

2 Data Compilation #PharmaFlow, 15 News #PharmaBuzz

2 Data Compilation #PharmaFlow
15 News #PharmaBuzz

GLOBAL SALES INFORMATION

4 US Medicaid Prescriptions, 10 Annual Reports

4 US Medicaid Prescriptions
10 Annual Reports

MARKET PLACE

2 APIs, 6 FDF Dossiers

2 APIs
6 FDF Dossiers

PATENTS & EXCLUSIVITIES

2 Health Canada Patents

2 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 USP

3 USP

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 2,784 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

8 All

01 1APOTEX

02 1EUGIA PHARMA

03 2NOVARTIS

04 1NOVUGEN

05 1SUN PHARM

06 1TEVA PHARMS INC

07 1TORRENT

filter Dosage Reset all filters

8 All

01 8TABLET;ORAL

filter Regulatory Info Reset all filters

8 All

01 1DISCN

02 7RX

filter Brand Name Reset all filters

8 All

01 6PAZOPANIB HYDROCHLORIDE

02 2VOTRIENT

filter RLD Reset all filters

8 All

01 6No

02 2Yes

List of Suppliers

Product Main Page

01

APOTEX

Organic Process R&D

Not Confirmed

APOTEX

Organic Process R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

RLD : No

TE Code : AB

PAZOPANIB HYDROCHLORIDE

Brand Name : PAZOPANIB HYDROCHLORIDE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 200MG BASE

Approval Date : 2023-10-19

Application Number : 217713

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

TEVA PHARMS INC

Organic Process R&D

Not Confirmed

TEVA PHARMS INC

Organic Process R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

RLD : No

TE Code : AB

PAZOPANIB HYDROCHLORIDE

Brand Name : PAZOPANIB HYDROCHLORIDE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 200MG BASE

Approval Date : 2023-10-19

Application Number : 217517

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

EUGIA PHARMA

Organic Process R&D

Not Confirmed

EUGIA PHARMA

Organic Process R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

RLD : No

TE Code : AB

PAZOPANIB HYDROCHLORIDE

Brand Name : PAZOPANIB HYDROCHLORIDE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 200MG BASE

Approval Date : 2024-12-04

Application Number : 219034

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

NOVARTIS

Organic Process R&D

Not Confirmed

NOVARTIS

Organic Process R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

RLD : Yes

TE Code : AB

PAZOPANIB HYDROCHLORIDE

Brand Name : VOTRIENT

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 200MG BASE

Approval Date : 2009-10-19

Application Number : 22465

RX/OTC/DISCN : RX

RLD : Yes

TE Code : AB

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

NOVARTIS

Organic Process R&D

Not Confirmed

NOVARTIS

Organic Process R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

RLD : Yes

TE Code :

PAZOPANIB HYDROCHLORIDE

Brand Name : VOTRIENT

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 400MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date : 2009-10-19

Application Number : 22465

RX/OTC/DISCN : DISCN

RLD : Yes

TE Code :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

NOVUGEN

Organic Process R&D

Not Confirmed

NOVUGEN

Organic Process R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

RLD : No

TE Code : AB

PAZOPANIB HYDROCHLORIDE

Brand Name : PAZOPANIB HYDROCHLORIDE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 200MG BASE

Approval Date : 2024-04-23

Application Number : 218231

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

07

SUN PHARM

Organic Process R&D

Not Confirmed

SUN PHARM

Organic Process R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

RLD : No

TE Code : AB

PAZOPANIB HYDROCHLORIDE

Brand Name : PAZOPANIB HYDROCHLORIDE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 200MG BASE

Approval Date : 2023-10-19

Application Number : 215837

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

08

TORRENT

Organic Process R&D

Not Confirmed

TORRENT

Organic Process R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

RLD : No

TE Code :

PAZOPANIB HYDROCHLORIDE

Brand Name : PAZOPANIB HYDROCHLORIDE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 400MG BASE

Approval Date : 2025-09-04

Application Number : 219922

RX/OTC/DISCN : RX

RLD : No

TE Code :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!